Gary Dahl
Publications
- Prognostic features in acute megakaryoblastic leukemia in children without Down syndrome: a report from the AML02 multicenter trial and the Children's Oncology Group Study POG 9421. Leukemia. 2013; (3): 731-4
- Comparative analysis of different approaches to measure treatment response in acute myeloid leukemia. J Clin Oncol. 2012; (29): 3625-32
- Concurrent cyclophosphamide and craniospinal radiotherapy for pediatric high-risk embryonal brain tumors. J Neurooncol. 2012; (2): 287-91
- Massive evolution of the immunoglobulin heavy chain locus in children with B precursor acute lymphoblastic leukemia. Blood. 2012; (22): 4407-17
- Therapeutic complications in a patient with high-risk acute lymphoblastic leukemia and undiagnosed hereditary hemochromatosis. Pediatr Blood Cancer. 2012; (1): 101-3
- Concurrent treatment of steroid-related mood and psychotic symptoms with risperidone. Pediatrics. 2010; (5): e1241-5
- Langerhans cell histiocytosis in a 5-month-old presenting with biparietal masses. J Neurosurg Pediatr. 2010; (4): 393-7
- Phase I study of valspodar (PSC-833) with mitoxantrone and etoposide in refractory and relapsed pediatric acute leukemia: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2010; (5): 694-702
- Tissue microarrays from bone marrow aspirates for high-throughput assessment of immunohistologic markers in pediatric acute leukemia. Pediatr Dev Pathol. 2008 Jul-Aug; (4): 283-90
- Cardiomyopathy in children with Down syndrome treated for acute myeloid leukemia: a report from the Children's Oncology Group Study POG 9421. J Clin Oncol. 2008; (3): 414-20
- Concerns about infertility risks among pediatric oncology patients and their parents. Pediatr Blood Cancer. 2008; (1): 85-9
- Identification of a novel p53 in-frame deletion in a Li-Fraumeni-like family. Pediatr Blood Cancer. 2008; (4): 914-6
- A syndrome of irreversible leukoencephalopathy following pediatric allogeneic bone marrow transplantation. Pediatr Blood Cancer. 2007; (2): 213-7
- Attitudes and practices of pediatric oncology providers regarding fertility issues. Pediatr Blood Cancer. 2007; (1): 80-5
- In cyclosporine-induced neurotoxicity, is tacrolimus an appropriate substitute or is it out of the frying pan and into the fire?-Response. Pediatr Blood Cancer. 2007
- Outcomes of transplantation in children with primary hepatic malignancy. Pediatr Transplant. 2007; (6): 655-60
- Reinduction of relapsed acute promyelocytic leukemia with ATRA and low dose antimetabolite-based chemotherapy. Pediatr Blood Cancer. 2007; (5): 582-5
- Anthracyclines cause endothelial injury in pediatric cancer patients: a pilot study. J Clin Oncol. 2006; (6): 925-8
- CpG island methylator phenotype and childhood leukemia. Clin Cancer Res. 2006; (16): 4787-9
- Profile of daily life in children with brain tumors: an assessment of health-related quality of life. J Clin Oncol. 2005; (24): 5493-500
- Gene expression profiles at diagnosis in de novo childhood AML patients identify FLT3 mutations with good clinical outcomes. Blood. 2004; (9): 2646-54
- Pharmacokinetic interactions of cyclosporine with etoposide and mitoxantrone in children with acute myeloid leukemia. Leukemia. 2002; (5): 920-7
- Modified cyclophosphamide, hydroxydaunorubicin, vincristine, and prednisone therapy for posttransplantation lymphoproliferative disease in pediatric patients undergoing solid organ transplantation. J Pediatr Hematol Oncol. 2001; (7): 452-5
- Surveillance neuroimaging to detect relapse in childhood brain tumors: a Pediatric Oncology Group study. J Clin Oncol. 2001; (21): 4135-40
- Management of children with metastatic spinal myxopapillary ependymoma using craniospinal irradiation. Med Pediatr Oncol. 2000; (4): 443-5
- Mitoxantrone, etoposide, and cyclosporine therapy in pediatric patients with recurrent or refractory acute myeloid leukemia. J Clin Oncol. 2000; (9): 1867-75
- A multi-institutional retrospective study of intracranial ependymoma in children: identification of risk factors. J Pediatr Hematol Oncol. 1999 May-Jun; (3): 203-11
- BCL-2 expression does not not correlate with patient outcome in pediatric acute myelogenous leukemia. Leuk Res. 1998; (1): 81-7
- Neoplastic disorders after pediatric heart transplantation. Circulation. 1993; (5 Pt 2): II230-7
Help
Trial Administration